Exosome may be the next generation of promising cell-free vaccines

被引:16
作者
Dai, Zelan [1 ,2 ]
Cai, Ruiru [2 ]
Zeng, Hong [2 ]
Zhu, Hailian [2 ]
Dou, Youwei [2 ]
Sun, Shibo [1 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, 295 Xichang Rd, Kunming, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Dept Biol Prod 7, Kunming, Peoples R China
基金
中国国家自然科学基金;
关键词
Exosome; vaccine; engineering; isolation; purification; cancer; SARS-CoV-2; NATURAL-KILLER-CELLS; EXTRACELLULAR VESICLES; DELIVERY; IMMUNOTHERAPY; NANOMEDICINE; NANOCARRIERS; VEHICLES;
D O I
10.1080/21645515.2024.2345940
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Traditional vaccines have limits against some persistent infections and pathogens. The development of novel vaccine technologies is particularly critical for the future. Exosomes play an important role in physiological and pathological processes. Exosomes present many advantages, such as inherent capacity being biocompatible, non-toxic, which make them a more desirable candidate for vaccines. However, research on exosomes are in their infancy and the barriers of low yield, low purity, and weak targeting of exosomes limit their applications in vaccines. Accordingly, further exploration is necessary to improve these problems and subsequently facilitate the functional studies of exosomes. In this study, we reviewed the origin, classification, functions, modifications, separation and purification, and characterization methods of exosomes. Meanwhile, we focused on the role and mechanism of exosomes for cancer and COVID-19 vaccines.
引用
收藏
页数:11
相关论文
共 110 条
[1]   Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications [J].
Amiri, Ala ;
Bagherifar, Rafieh ;
Dezfouli, Ehsan Ansari ;
Kiaie, Seyed Hossein ;
Jafari, Reza ;
Ramezani, Reihaneh .
JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
[2]  
Bae Susan, 2018, Genes Cancer, V9, P87, DOI [10.18632/genesandcancer.172, 10.18632/genesandcancer.172]
[3]   Using exosomes, naturally-equipped nanocarriers, for drug delivery [J].
Batrakova, Elena V. ;
Kim, Myung Soo .
JOURNAL OF CONTROLLED RELEASE, 2015, 219 :396-405
[4]   Exosomes: an overview of biogenesis, composition and role in ovarian cancer [J].
Beach, Allison ;
Zhang, Huang-Ge ;
Ratajczak, Mariusz Z. ;
Kakar, Sham S. .
JOURNAL OF OVARIAN RESEARCH, 2014, 7
[5]   Macrophage cell-derived exosomes/staphylococcal enterotoxin B against fibrosarcoma tumor [J].
Behzadi, Elham ;
Hosseini, Hamideh Mahmoodzadeh ;
Halabian, Raheleh ;
Fooladi, Abbas Ali Imani .
MICROBIAL PATHOGENESIS, 2017, 111 :132-138
[6]   Composition and Clinical Significance of Exosomes in Tuberculosis: A Systematic Literature Review [J].
Biadglegne, Fantahun ;
Koenig, Brigitte ;
Rodloff, Arne C. ;
Dorhoi, Anca ;
Sack, Ulrich .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) :1-18
[7]   Exosomes from Myeloid-Derived Suppressor Cells Carry Biologically Active Proteins [J].
Burke, Meghan ;
Choksawangkarn, Waeowalee ;
Edwards, Nathan ;
Ostrand-Rosenberg, Suzanne ;
Fenselau, Catherine .
JOURNAL OF PROTEOME RESEARCH, 2014, 13 (02) :836-843
[8]   Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives [J].
Butreddy, Arun ;
Kommineni, Nagavendra ;
Dudhipala, Narendar .
NANOMATERIALS, 2021, 11 (06)
[9]   Exosome-based immunotherapy [J].
Chaput, N ;
Taïeb, J ;
Schartz, NEC ;
André, F ;
Angevin, E ;
Zitvogel, L .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (03) :234-239
[10]  
Chaput N, 2003, ADV EXP MED BIOL, V532, P215